LONG TAM: Open Payments
NPI 1225741382 · EL MONTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 12 payments from 10 companies in 2025. Trend: 2023 $1,114 · 2024 $1,174 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $48 |
| Verona Pharma, Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $27 |
| Pulmonx Corporation | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Philips North America LLC | 1 | $14 |
Products named: TRELEGY ELLIPTA, Ohtuvayre, QULIPTA, CHARTIS CATHETER, WINREVAIR, OPSUMIT, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
